<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00794456</url>
  </required_header>
  <id_info>
    <org_study_id>MJ 3002-08</org_study_id>
    <nct_id>NCT00794456</nct_id>
  </id_info>
  <brief_title>Association of Passiflora Incarnata L; Crataegus Oxyacantha L and Salix Alba L. on Mild and Moderate Anxiety</brief_title>
  <official_title>Double Blind, Randomized Study, Controlled by Valeriana Officinalis, of Association of Passiflora Incarnata L; Crataegus Oxyacantha L and Salix Alba L. on Patients With Mild and Moderate Anxiety</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Marjan Industria e Comercio ltda</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Marjan Industria e Comercio ltda</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Phase III, multicentric, double blind, randomized study, controlled by Valeriana officinalis
      for evaluating the efficacy of association of Passiflora incarnata L; Crataegus Oxyacantha L
      and Salix alba L. on mild and moderate anxiety. The treatment period will last 6 weeks and be
      followed by a post treatment visit.

      Hamilton anxiety scale will be used to assess anxiety.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Passiflora incarnata L; Crataegus Oxyacantha L are plant-derived treatment widely used to
      treat anxiety disorders. This study will compare the association of Passiflora incarnata L;
      Crataegus Oxyacantha L and Salix alba L for the treatment of mild and moderate anxiety. 150
      participants will be randomly assigned to receive the association of Passiflora incarnata L;
      Crataegus Oxyacantha L and Salix alba L. or Valeriana officinalis for 6 weeks. A post
      treatment visit will be done 2 weeks for safety evaluation.

      Primary outcome: Hamilton anxiety (HAM-A) scale Secondary outcome: Insomnia quality index,
      Global clinical impression and patients global evaluation scales.

      Side effects will be monitorized throughout the study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hamilton anxiety scale</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Insomnia gravity index; global clinical impression; patients global evaluation</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Anxiety Disorder</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Association of Passiflora incarnata L; Crataegus Oxyacantha L and Salix alba L.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Valeriana officinalis 50 mg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Passiflora ; Crataegus and Salix</intervention_name>
    <description>1 tablet PO twice a day</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Pasalix</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Valeriana</intervention_name>
    <description>1 tablet PO twice a day</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Valeriana officinalis 50 mg</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  generalized anxiety disorder

          -  HAM-A scale &lt; 17 and &gt; 30

        Exclusion Criteria:

          -  hypersensibility to any component

          -  patients with depression, schizophrenia ou suicidal ideas

          -  pregnant ou lactating

          -  heart, liver, lung or kidney important condition

          -  use of digitalis, AAS, anticoagulants agents, drugs with sedative or antidepressant
             action

          -  psychotherapy

          -  drug or alcohol dependence

          -  gastrointestinal ulcer history

          -  hyperthyroidism

          -  neoplasia

          -  coagulation disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maria Elisabete A Moraes, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Ceará</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonio C Lopes, Phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Sao Paulo - UNIFESP / DPDM - Associação Paulista para o Desenvolvimento da Medicina - Hospital São Paulo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Unidade de Farmacologia Clínica - UNIFAC</name>
      <address>
        <city>Fortaleza</city>
        <state>Ceará</state>
        <zip>60430-270</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SPDM - Associação Paulista para o Desenvolvimento da Medicina - Hospital São Paulo</name>
      <address>
        <city>Sao Paulo</city>
        <zip>04024-002</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 19, 2008</study_first_submitted>
  <study_first_submitted_qc>November 19, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2008</study_first_posted>
  <last_update_submitted>July 7, 2014</last_update_submitted>
  <last_update_submitted_qc>July 7, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 8, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Passiflora</keyword>
  <keyword>Crataegus</keyword>
  <keyword>Herbal</keyword>
  <keyword>Valeriana</keyword>
  <keyword>anxiety</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

